Pre-Competitive Collaboration Would Help Pharmaceutical Productivity Crisis - If Lawyers Could Get Out Of The Way
This article was originally published in The Pink Sheet Daily
Executive Summary
Pre-commercial collaborations and R&D network expansions fall in the cross hairs of IP lawyers, who look to protect everything they can as intellectual property. But with big pharma desperate to speed up drug development and conserve resources, it's likely the R&D heads have the upper hand, at least for now.